RGLS logo

Regulus Therapeutics (RGLS) Retained Earnings

Annual Retained Earnings

-$513.21 M
-$30.04 M-6.22%

31 December 2023

RGLS Retained Earnings Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Retained Earnings

-$546.78 M
-$14.06 M-2.64%

30 September 2024

RGLS Quarterly Retained Earnings Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

RGLS Retained Earnings Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-6.2%-8.2%
3 y3 years-20.2%-22.1%
5 y5 years-30.7%-34.5%

RGLS Retained Earnings High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-20.2%at low-22.1%at low
5 y5 years-30.7%at low-34.5%at low
alltimeall time-1093.2%at low-1171.3%at low

Regulus Therapeutics Retained Earnings History

DateAnnualQuarterly
Sept 2024
-
-$546.78 M(+2.6%)
June 2024
-
-$532.72 M(+2.1%)
Mar 2024
-
-$521.68 M(+1.7%)
Dec 2023
-$513.21 M(+6.2%)
-$513.21 M(+1.6%)
Sept 2023
-
-$505.15 M(+1.6%)
June 2023
-
-$497.33 M(+1.4%)
Mar 2023
-
-$490.31 M(+1.5%)
Dec 2022
-$483.18 M(+6.2%)
-$483.18 M(+1.4%)
Sept 2022
-
-$476.38 M(+1.6%)
June 2022
-
-$468.83 M(+1.6%)
Mar 2022
-
-$461.57 M(+1.5%)
Dec 2021
-$454.85 M(+6.5%)
-$454.85 M(+1.6%)
Sept 2021
-
-$447.72 M(+2.0%)
June 2021
-
-$439.09 M(+1.4%)
Mar 2021
-
-$433.06 M(+1.4%)
Dec 2020
-$427.05 M(+3.8%)
-$427.05 M(+0.3%)
Sept 2020
-
-$425.72 M(+0.4%)
June 2020
-
-$424.20 M(+1.7%)
Mar 2020
-
-$417.25 M(+1.4%)
Dec 2019
-$411.31 M(+4.7%)
-$411.31 M(+1.2%)
Sept 2019
-
-$406.42 M(+1.4%)
June 2019
-
-$401.00 M(+1.3%)
Mar 2019
-
-$395.98 M(+0.8%)
Dec 2018
-$392.72 M
-$392.72 M(+2.2%)
Sept 2018
-
-$384.16 M(+2.7%)
DateAnnualQuarterly
June 2018
-
-$373.89 M(+3.8%)
Mar 2018
-
-$360.04 M(+4.1%)
Dec 2017
-$345.86 M(+26.5%)
-$345.86 M(+4.4%)
Sept 2017
-
-$331.41 M(+5.0%)
June 2017
-
-$315.58 M(+7.4%)
Mar 2017
-
-$293.97 M(+7.5%)
Dec 2016
-$273.35 M(+42.7%)
-$273.35 M(+7.9%)
Sept 2016
-
-$253.33 M(+8.3%)
June 2016
-
-$233.81 M(+9.9%)
Mar 2016
-
-$212.72 M(+11.1%)
Dec 2015
-$191.51 M(+41.1%)
-$191.51 M(+3.9%)
Sept 2015
-
-$184.29 M(+7.6%)
June 2015
-
-$171.29 M(+14.0%)
Mar 2015
-
-$150.25 M(+10.7%)
Dec 2014
-$135.77 M(+71.7%)
-$135.77 M(+19.5%)
Sept 2014
-
-$113.60 M(+9.4%)
June 2014
-
-$103.80 M(+13.0%)
Mar 2014
-
-$91.83 M(+16.1%)
Dec 2013
-$79.09 M(+30.9%)
-$79.09 M(+2.5%)
Sept 2013
-
-$77.16 M(+2.9%)
June 2013
-
-$75.00 M(+10.9%)
Mar 2013
-
-$67.65 M(+12.0%)
Dec 2012
-$60.42 M(+40.5%)
-$60.42 M(+12.8%)
Sept 2012
-
-$53.54 M(+11.9%)
June 2012
-
-$47.86 M(+11.3%)
Dec 2011
-$43.01 M
-$43.01 M

FAQ

  • What is Regulus Therapeutics annual retained earnings?
  • What is the all time high annual retained earnings for Regulus Therapeutics?
  • What is Regulus Therapeutics annual retained earnings year-on-year change?
  • What is Regulus Therapeutics quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Regulus Therapeutics?
  • What is Regulus Therapeutics quarterly retained earnings year-on-year change?

What is Regulus Therapeutics annual retained earnings?

The current annual retained earnings of RGLS is -$513.21 M

What is the all time high annual retained earnings for Regulus Therapeutics?

Regulus Therapeutics all-time high annual retained earnings is -$43.01 M

What is Regulus Therapeutics annual retained earnings year-on-year change?

Over the past year, RGLS annual retained earnings has changed by -$30.04 M (-6.22%)

What is Regulus Therapeutics quarterly retained earnings?

The current quarterly retained earnings of RGLS is -$546.78 M

What is the all time high quarterly retained earnings for Regulus Therapeutics?

Regulus Therapeutics all-time high quarterly retained earnings is -$43.01 M

What is Regulus Therapeutics quarterly retained earnings year-on-year change?

Over the past year, RGLS quarterly retained earnings has changed by -$41.63 M (-8.24%)